ALNY
Alnylam Pharmaceuticals Inc.
$446.51
-$5.82(-1.29%)
68
Overall
40
Value
100
Tech
65
Quality
Market Cap
$59.14B
Volume
827.61K
52W Range
$205.87 - $469.81
Target Price
$436.15
EPS Estimates Overview
| Current Quarter | $0.45 | Next Quarter | $0.84 |
| Current Year | $0.44 | Next Year | $5.5 |
| QoQ Growth | +86.7% | YoY Growth | +1150.0% |
| 3Y EPS CAGR | +25.8% | Target Price | $436.15 |
| Consensus | Buy | Upside | -2.3% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ALNY | $446.51 | -1.3% | 827.61K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Alnylam Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW